180 related articles for article (PubMed ID: 8590314)
1. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
Brod SA; Scott M; Burns DK; Phillips JT
J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
Brod SA; Khan M
J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.
Brod SA; Khan M; Kerman RH; Pappolla M
J Neuroimmunol; 1995 Apr; 58(1):61-9. PubMed ID: 7537281
[TBL] [Abstract][Full Text] [Related]
6. Decreased production of TNF-alpha by lymph node cells indicates experimental autoimmune encephalomyelitis remission in Lewis rats.
Seger J; Zorzella-Pezavento SF; Pelizon AC; Martins DR; Domingues A; Sartori A
Mem Inst Oswaldo Cruz; 2010 May; 105(3):263-8. PubMed ID: 20512238
[TBL] [Abstract][Full Text] [Related]
7. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
8. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
[TBL] [Abstract][Full Text] [Related]
9. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
Hinrichs DJ; Roberts CM; Waxman FJ
J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
[TBL] [Abstract][Full Text] [Related]
10. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
[TBL] [Abstract][Full Text] [Related]
11. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
12. T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats.
Mustafa MI; Diener P; Höjeberg B; Van der Meide P; Olsson T
J Neuroimmunol; 1991 Feb; 31(2):165-77. PubMed ID: 1704016
[TBL] [Abstract][Full Text] [Related]
13. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
[TBL] [Abstract][Full Text] [Related]
14. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
Killen JA; Swanborg RH
J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
Whitacre CC; Gienapp IE; Orosz CG; Bitar DM
J Immunol; 1991 Oct; 147(7):2155-63. PubMed ID: 1717550
[TBL] [Abstract][Full Text] [Related]
17. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells.
Welch AM; Swierkosz JE; Swanborg RH
J Immunol; 1978 Nov; 121(5):1701-5. PubMed ID: 309479
[No Abstract] [Full Text] [Related]
18. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan.
Kim H; Moon C; Park EJ; Jee Y; Ahn M; Wie MB; Shin T
Phytother Res; 2010 Mar; 24(3):399-403. PubMed ID: 19655293
[TBL] [Abstract][Full Text] [Related]
20. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons.
Brod SA; Burns DK
Neurology; 1994 Jun; 44(6):1144-8. PubMed ID: 8208413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
